Ion channels as targets to treat cystic fibrosis lung disease

Journal of Cystic Fibrosis

Volumn 17, Issue 2, 2018, Pages S22-S27

  Martin, S Lorraine ^a   Saint Criq, Vinciane ^b   Hwang, Tzyh Chang ^c   Csanády, László ^d  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MISSOURI   (United States)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Airways hydration; Anion exchanger; CFTR; Cystic fibrosis; ENaC; Ion channel; Ion transporter; Proteases

Indexed keywords

CHLORIDE CHANNEL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM CHANNEL; ION CHANNEL;

CYSTIC FIBROSIS; DRUG DEVELOPMENT; DRUG TARGETING; LUNG DISEASE; MUCOCILIARY CLEARANCE; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; DRUG EFFECT; GENETICS; HUMAN; ION TRANSPORT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DRUG DISCOVERY; HUMANS; ION TRANSPORT; MUCOCILIARY CLEARANCE;

EID: 85033447749     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2017.10.006     Document Type: Review

References (53)

1. Elborn, J.S., Cystic fibrosis. Lancet 388 (2016), 2519–2531.
2. De Boeck, K., Amaral, M.D., Progress in therapies for cystic fibrosis. Lancet Respir Med 4 (2016), 662–674.
3. Knowles, M.R., Boucher, R.C., Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109 (2002), 571–577.
4. Knowles, M.R., Stutts, M.J., Spock, A., Fischer, N., Gatzy, J.T., Boucher, R.C., Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221 (1983), 1067–1070.
5. Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989), 1066–1073.
6. Anderson, M.P., Berger, H.A., Rich, D.P., Gregory, R.J., Smith, A.E., Welsh, M.J., Nucleoside triphosphates are required to open the CFTR chloride channel. Cell 67 (1991), 775–784.
7. Liu, F., Zhang, Z., Csanady, L., Gadsby, D.C., Chen, J., Molecular structure of the human CFTR ion channel. Cell 169 (2017), 85–95 e8.
8. Vergani, P., Lockless, S.W., Nairn, A.C., Gadsby, D.C., CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433 (2005), 876–880.
9. Basso, C., Vergani, P., Nairn, A.C., Gadsby, D.C., Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating. J Gen Physiol 122 (2003), 333–348.
10. Ramjeesingh, M., Li, C., Garami, E., Huan, L.J., Galley, K., Wang, Y., et al. Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator). Biochemistry 38 (1999), 1463–1468.
11. Sorum, B., Czege, D., Csanady, L., Timing of CFTR pore opening and structure of its transition state. Cell 163 (2015), 724–733.
12. Csanady, L., Mihalyi, C., Szollosi, A., Torocsik, B., Vergani, P., Conformational changes in the catalytically inactive nucleotide-binding site of CFTR. J Gen Physiol 142 (2013), 61–73.
13. Tsai, M.F., Jih, K.Y., Shimizu, H., Li, M., Hwang, T.C., Optimization of the degenerated interfacial ATP binding site improves the function of disease-related mutant cystic fibrosis transmembrane conductance regulator (CFTR) channels. J Biol Chem 285 (2010), 37663–37671.
14. Chaves, L.A., Gadsby, D.C., Cysteine accessibility probes timing and extent of NBD separation along the dimer interface in gating CFTR channels. J Gen Physiol 145 (2015), 261–283.
15. Szollosi, A., Muallem, D.R., Csanady, L., Vergani, P., Mutant cycles at CFTR's non-canonical ATP-binding site support little interface separation during gating. J Gen Physiol 137 (2011), 549–562.
16. Tsai, M.F., Li, M., Hwang, T.C., Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. J Gen Physiol 135 (2010), 399–414.
17. Mihalyi, C., Torocsik, B., Csanady, L., Obligate coupling of CFTR pore opening to tight nucleotide-binding domain dimerization. Elife, 5, 2016.
18. Zhou, Z., Wang, X., Liu, H.Y., Zou, X., Li, M., Hwang, T.C., The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics. J Gen Physiol 128 (2006), 413–422.
19. Powe, A.C. Jr., Al-Nakkash, L., Li, M., Hwang, T.C., Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains. J Physiol 539 (2002), 333–346.
20. Vergani, P., Nairn, A.C., Gadsby, D.C., On the mechanism of MgATP-dependent gating of CFTR Cl- channels. J Gen Physiol 121 (2003), 17–36.
21. Gunderson, K.L., Kopito, R.R., Conformational states of CFTR associated with channel gating: the role ATP binding and hydrolysis. Cell 82 (1995), 231–239.
22. Bompadre, S.G., Sohma, Y., Li, M., Hwang, T.C., G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. J Gen Physiol 129 (2007), 285–298.
23. Fajac, I., De Boeck, K., New horizons for cystic fibrosis treatment. Pharmacol Ther 170 (2017), 205–211.
24. Gaillard, E.A., Kota, P., Gentzsch, M., Dokholyan, N.V., Stutts, M.J., Tarran, R., Regulation of the epithelial Na + channel and airway surface liquid volume by serine proteases. Pflugers Arch 460 (2010), 1–17.
25. Canessa, C.M., Schild, L., Buell, G., Thorens, B., Gautschi, I., Horisberger, J.D., et al. Amiloride-sensitive epithelial Na + channel is made of three homologous subunits. Nature 367 (1994), 463–467.
26. Garcia-Caballero, A., Rasmussen, J.E., Gaillard, E., Watson, M.J., Olsen, J.C., Donaldson, S.H., et al. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci U S A 106 (2009), 11412–11417.
27. Myerburg, M.M., Harvey, P.R., Heidrich, E.M., Pilewski, J.M., Butterworth, M.B., Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking. Am J Respir Cell Mol Biol 43 (2010), 712–719.
28. Gentzsch, M., Dang, H., Dang, Y., Garcia-Caballero, A., Suchindran, H., Boucher, R.C., et al. The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na + channel. J Biol Chem 285 (2010), 32227–32232.
29. Passero, C.J., Mueller, G.M., Rondon-Berrios, H., Tofovic, S.P., Hughey, R.P., Kleyman, T.R., Plasmin activates epithelial Na + channels by cleaving the gamma subunit. J Biol Chem 283 (2008), 36586–36591.
30. Hughey, R.P., Bruns, J.B., Kinlough, C.L., Harkleroad, K.L., Tong, Q., Carattino, M.D., et al. Epithelial sodium channels are activated by furin-dependent proteolysis. J Biol Chem 279 (2004), 18111–18114.
31. Garcia-Caballero, A., Dang, Y., He, H., Stutts, M.J., ENaC proteolytic regulation by channel-activating protease 2. J Gen Physiol 132 (2008), 521–535.
32. Bridges, R.J., Newton, B.B., Pilewski, J.M., Devor, D.C., Poll, C.T., Hall, R.L., Na + transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437. Am J Physiol Lung Cell Mol Physiol 281 (2001), L16–23.
33. Coote, K., Atherton-Watson, H.C., Sugar, R., Young, A., MacKenzie-Beevor, A., Gosling, M., et al. Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J Pharmacol Exp Ther 329 (2009), 764–774.
34. Reihill, J.A., Walker, B., Hamilton, R.A., Ferguson, T.E., Elborn, J.S., Stutts, M.J., et al. Inhibition of protease-epithelial Sodium Channel signaling improves mucociliary function in cystic fibrosis airways. Am J Respir Crit Care Med 194 (2016), 701–710.
35. Smith, N.J., Solovay, C.F., Epithelial Na + channel inhibitors for the treatment of cystic fibrosis. Pharm Pat Anal 6 (2017), 179–188.
36. Scott, D.W., Walker, M.P., Sesma, J., Wu, B., Stuhlmiller, T.J., Sabater, J.R., et al. SPX-101 is a novel ENaC-targeted therapeutic for cystic fibrosis that restores mucus transport. Am J Respir Crit Care Med, 2017.
37. Clark, K.L., Hughes, S.A., Bulsara, P., Coates, J., Moores, K., Parry, J., et al. Pharmacological characterization of a novel ENaCalpha siRNA (GSK2225745) with potential for the treatment of cystic fibrosis. Mol Ther Nucleic Acids, e65, 2013, 2.
38. Manunta, M.D., Tagalakis, A.D., Attwood, M., Aldossary, A.M., Barnes, J.L., Munye, M.M., et al. Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis. Sci Rep, 7, 2017, 700.
39. Caputo, A., Caci, E., Ferrera, L., Pedemonte, N., Barsanti, C., Sondo, E., et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 322 (2008), 590–594.
40. Schroeder, B.C., Cheng, T., Jan, Y.N., Jan, L.Y., Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 134 (2008), 1019–1029.
41. Yang, Y.D., Cho, H., Koo, J.Y., Tak, M.H., Cho, Y., Shim, W.S., et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 455 (2008), 1210–1215.
42. Jung, J., Nam, J.H., Park, H.W., Oh, U., Yoon, J.H., Lee, M.G., Dynamic modulation of ANO1/TMEM16A HCO3(−) permeability by Ca2 +/calmodulin. Proc Natl Acad Sci U S A 110 (2013), 360–365.
43. Scudieri, P., Caci, E., Bruno, S., Ferrera, L., Schiavon, M., Sondo, E., et al. Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia. J Physiol 590 (2012), 6141–6155.
44. Huang, F., Zhang, H., Wu, M., Yang, H., Kudo, M., Peters, C.J., et al. Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc Natl Acad Sci U S A 109 (2012), 16354–16359.
45. Liu, Y., Zhang, H., Huang, D., Qi, J., Xu, J., Gao, H., et al. Characterization of the effects of Cl(−) channel modulators on TMEM16A and bestrophin-1 Ca(2)(+) activated Cl(−) channels. Pflugers Arch 467 (2015), 1417–1430.
46. Seo, Y., Lee, H.K., Park, J., Jeon, D.K., Jo, S., Jo, M., et al. Ani9, a novel potent small-molecule ANO1 inhibitor with negligible effect on ANO2. PLoS One, 11, 2016, e0155771.
47. Pedemonte, N., Caci, E., Sondo, E., Caputo, A., Rhoden, K., Pfeffer, U., et al. Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: role of pendrin and anion channels. J Immunol 178 (2007), 5144–5153.
48. Garnett, J.P., Hickman, E., Burrows, R., Hegyi, P., Tiszlavicz, L., Cuthbert, A.W., et al. Novel role for pendrin in orchestrating bicarbonate secretion in cystic fibrosis transmembrane conductance regulator (CFTR)-expressing airway serous cells. J Biol Chem 286 (2011), 41069–41082.
49. Haggie, P.M., Phuan, P.W., Tan, J.A., Zlock, L., Finkbeiner, W.E., Verkman, A.S., Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis. FASEB J 30 (2016), 2187–2197.
50. Mall, M.A., Galietta, L.J., Targeting ion channels in cystic fibrosis. J Cyst Fibros 14 (2015), 561–570.
51. Devor, D.C., Bridges, R.J., Pilewski, J.M., Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. Am J Physiol Cell Physiol 279 (2000), C461–79.
52. Coakley, R.D., Grubb, B.R., Paradiso, A.M., Gatzy, J.T., Johnson, L.G., Kreda, S.M., et al. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci U S A 100 (2003), 16083–16088.
53. Shah, V.S., Meyerholz, D.K., Tang, X.X., Reznikov, L., Abou Alaiwa, M., Ernst, S.E., et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science 351 (2016), 503–507.